- Faculty
- BR1DGE
Chantal Mathieu
Katholieke Universiteit Leuven, Belgium
The community is gearing up for the most exciting times in T1D – detecting it at an early stage, and hopefully thus avoiding people still presenting in catastrophic circumstances at clinical diagnosis, in particular with diabetic ketoacidosis. In order for the field to progress, robust, clear educational materials need to be available and that is where the BR1DGE platform can make a difference. In our collaboration within the EDENT1FI consortium, we are excited to link up with this initiative!
Professor Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology through basic and clinical research. Her basic research work focuses on pathogenesis and prevention of type 1 diabetes.
Prof. Mathieu’s clinical work involving new products and treatment paradigms in diabetes, such as new insulins, adjunct therapies and diagnosis of gestational diabetes have made her a speaker in international fora. Prof. Mathieu coordinates the European clinical trial network for interventions in type 1 diabetes ‘INNODIA’ and the European project ‘EDENT1FI’ on screening for type 1 diabetes. Prof. Mathieu is president of EASD and vice-president of the European Diabetes Forum.
Sanofi provides financial support to various third-party organizations through grants or sponsorships. EDENT1FI is supported by IHI JU, grant No 101132379.